… that inhibit NET only at higher dosages (150-225 mg/d) [Citation48]. A weak binding affinity
… in managing cognitive complaints associated with major depressive episode has also been …

… safety and tolerability of desvenlafaxine for the treatment of children and adolescents with
… Desvenlafaxine 20 to 50 mg/d was generally safe and well tolerated with no new safety …

… was an effective antidepressant with favorable safety and tolerability in adults. … The
present article considers additional trials of desvenlafaxine in major depressive disorder. …

… of major depressive episodes (MDEs) and prior treatments between … safety profile of
desvenlafaxine XL in this study was similar to that in prior studies, without new safety or tolerability …

… Only data from placebo and desvenlafaxine 50- and 100-mg/d treatment arms were … efficacy
and tolerability of desvenlafaxine 10 and 50 mg/d in adult outpatients with major depressive …

… for the treatment of major depressive disorder (MDD). … to desvenlafaxine in vivo, ansofaxine
and desvenlafaxine can … (40–160 mg/d) demonstrated its safety, efficacy, and tolerability in …

… Using data from nine double-blind, placebo-controlled studies of desvenlafaxine for the
treatment of major depressive disorder (N=4317), the effect of desvenlafaxine 50 or 100 mg …

… Tolerability was assessed at each visit by self-rated scales and clinician … 50 mg equivalent
and 18 taking 100 mg equivalent; active drug non-responders (n = 9) were all taking 100 mg/d…

… is one more drug in the therapeutic arsenal available to treat depression, and … tolerability
or effectiveness. We were also unable to analyze the influence of Black race on desvenlafaxine …

… To maintain the blind, desvenlafaxine dose adjustment could … for desvenlafaxine, there is
no evidence that doses > 50 mg/d … perceptions of treatment efficacy and tolerability and has …